Delivery Order SPE2DB20D3505-SPE2DB23FU4L8
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,944.61 Firm Fixed Price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,247.84 firm fixed-price delivery order is for the pharmaceutical product Trulicity 3 mg/0.5 ml pen, which is used to treat diabetes. The contract has an ultimate completion date of December 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,612.52 firm fixed-price delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a completion date of July 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $3,004.24 firm-fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a prescription medication used to manage diabetes. The contract has an ultimate completion date of June 22, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.84 firm fixed price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $3,526.04 firm fixed-price contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of August 13, 2021 and was awarded on August 12, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is a delivery order valued at $5,639.12 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,355.66, is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,801.80 firm fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a diabetes medication. The contract is not designated as a set-aside and has an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 4.5 mg/0.5 ml pens. The single-award contract has a firm fixed price of $23,103.58 and a completion date of June 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU4L8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,450.08 firm-fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used for diabetes management. The contract has a completion date of July 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with a set-aside requirement, indicating open competition. This contract supports the DLA's role in supplying essential medications and medical commodities to the Department of Defense and other federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/24/23 |